Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Edgewise Therapeutics Inc (NASDAQ: EWTX) closed the day trading at $23.59 down -0.51% from the previous closing price of $23.71. In other words, the price has decreased by -$0.51 from its previous closing price. On the day, 0.76 million shares were traded. EWTX stock price reached its highest trading level at $24.26 during the session, while it also had its lowest trading level at $23.475.
Ratios:
For a better understanding of EWTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.51 and its Current Ratio is at 26.51. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on September 25, 2025, initiated with a Neutral rating and assigned the stock a target price of $20.
On July 30, 2025, Raymond James started tracking the stock assigning a Strong Buy rating and target price of $46.
On June 30, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $42.H.C. Wainwright initiated its Buy rating on June 30, 2025, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 17 ’25 when ROBERT MICHAEL CARRUTHERS bought 70,000 shares for $22.38 per share.
Russell Alan J sold 100,000 shares of EWTX for $2,112,450 on Nov 12 ’25. The Chief Scientific Officer now owns 23,400 shares after completing the transaction at $21.12 per share. On Nov 11 ’25, another insider, Fox Jonathan C, who serves as the Director of the company, bought 10,700 shares for $18.64 each. As a result, the insider paid 199,403 and bolstered with 23,702 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EWTX now has a Market Capitalization of 2497436416 and an Enterprise Value of 1938277376.
Stock Price History:
The Beta on a monthly basis for EWTX is 0.28, which has changed by -0.2199074 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, EWTX has reached a high of $35.50, while it has fallen to a 52-week low of $10.60. The 50-Day Moving Average of the stock is 26.97%, while the 200-Day Moving Average is calculated to be 40.24%.
Shares Statistics:
Over the past 3-months, EWTX traded about 1.04M shares per day on average, while over the past 10 days, EWTX traded about 1118920 shares per day. A total of 105.76M shares are outstanding, with a floating share count of 76.32M. Insiders hold about 27.91% of the company’s shares, while institutions hold 79.02% stake in the company. Shares short for EWTX as of 1763078400 were 10045672 with a Short Ratio of 9.69, compared to 1760486400 on 8616447. Therefore, it implies a Short% of Shares Outstanding of 10045672 and a Short% of Float of 11.129999999999999.
Earnings Estimates
The stock of Edgewise Therapeutics Inc (EWTX) is currently drawing attention from 11.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.39 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.56 and -$1.66 for the fiscal current year, implying an average EPS of -$1.6. EPS for the following year is -$1.98, with 10.0 analysts recommending between -$1.5 and -$2.34.
